SE385882B - Sett att framstella nya 3,4-dihydropyridoner - Google Patents

Sett att framstella nya 3,4-dihydropyridoner

Info

Publication number
SE385882B
SE385882B SE7311813A SE7311813A SE385882B SE 385882 B SE385882 B SE 385882B SE 7311813 A SE7311813 A SE 7311813A SE 7311813 A SE7311813 A SE 7311813A SE 385882 B SE385882 B SE 385882B
Authority
SE
Sweden
Prior art keywords
dihydropyridones
way
produce new
produce
new
Prior art date
Application number
SE7311813A
Other languages
English (en)
Inventor
H Meyer
F Bossert
W Vater
K Stoepel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SE385882B publication Critical patent/SE385882B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
SE7311813A 1972-08-31 1973-08-30 Sett att framstella nya 3,4-dihydropyridoner SE385882B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2242787A DE2242787C2 (de) 1972-08-31 1972-08-31 4-Phenyl-6-amino-3,4-dihydropyridon-(2)-3,5-dicarbonsäure-diäthylesterderivate, ein Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
SE385882B true SE385882B (sv) 1976-07-26

Family

ID=5855065

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7311813A SE385882B (sv) 1972-08-31 1973-08-30 Sett att framstella nya 3,4-dihydropyridoner

Country Status (21)

Country Link
US (1) US3925395A (sv)
JP (1) JPS5626661B2 (sv)
AT (1) AT327902B (sv)
AU (1) AU476373B2 (sv)
BE (1) BE804161A (sv)
CA (1) CA1016946A (sv)
CH (1) CH592061A5 (sv)
DD (1) DD109628A5 (sv)
DE (1) DE2242787C2 (sv)
DK (1) DK131855C (sv)
ES (1) ES418340A1 (sv)
FR (1) FR2197598B1 (sv)
GB (1) GB1389505A (sv)
HU (1) HU167992B (sv)
IE (1) IE38141B1 (sv)
IL (1) IL43080A (sv)
LU (1) LU68325A1 (sv)
NL (1) NL7311832A (sv)
PL (1) PL89430B1 (sv)
SE (1) SE385882B (sv)
ZA (1) ZA735973B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002762A (en) * 1973-03-03 1977-01-11 Bayer Aktiengesellschaft 2-Amino-3,4-dihydropyridines used to effect coronary vessel dilation and treat hypertension
IT8367883A0 (it) * 1982-08-23 1983-08-22 Rorer Int Overseas Composti cardiotonici del 2 piridone 5 biciclico eteroaril sostituito e relative composizioni farmaceutiche
WO1993009774A1 (en) * 1991-11-18 1993-05-27 G.D. Searle & Co. 2-(4-substituted)phenylmethylene derivatives and methods of use
AU2003293356A1 (en) 2002-08-27 2004-03-19 Bayer Healthcare Ag Dihydropyridinone derivatives as hne inhibitors
US20050252833A1 (en) * 2004-05-14 2005-11-17 Doyle James A Process and apparatus for converting oil shale or oil sand (tar sand) to oil

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
DE2013431C3 (de) * 1970-03-20 1979-12-20 Bayer Ag, 5090 Leverkusen 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester
DE2003146A1 (de) * 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate

Also Published As

Publication number Publication date
ZA735973B (en) 1974-10-30
LU68325A1 (sv) 1973-10-30
DD109628A5 (sv) 1974-11-12
AU5983573A (en) 1975-03-06
BE804161A (fr) 1974-02-28
IL43080A0 (en) 1973-11-28
FR2197598B1 (sv) 1977-07-15
PL89430B1 (sv) 1976-11-30
DE2242787C2 (de) 1982-01-21
IE38141B1 (en) 1978-01-04
AU476373B2 (en) 1976-09-16
ES418340A1 (es) 1976-03-16
GB1389505A (en) 1975-04-03
DK131855C (da) 1976-02-16
DE2242787A1 (de) 1974-03-14
ATA760073A (de) 1975-05-15
JPS4962483A (sv) 1974-06-17
DK131855B (da) 1975-09-15
IL43080A (en) 1977-01-31
CH592061A5 (sv) 1977-10-14
IE38141L (en) 1974-02-28
FR2197598A1 (sv) 1974-03-29
CA1016946A (en) 1977-09-06
US3925395A (en) 1975-12-09
AT327902B (de) 1976-02-25
HU167992B (sv) 1976-02-28
NL7311832A (sv) 1974-03-04
JPS5626661B2 (sv) 1981-06-19

Similar Documents

Publication Publication Date Title
SE7614680L (sv) Sett att framstella nya bensodiazepinderivat
SE421615B (sv) Sett att framstella nya tiazolderivat
SE403777B (sv) Sett att framstella nya 1,4-dihydropyridin-polyestrar
SE411349B (sv) Sett att framstella nya penicilliner
SE7711848L (sv) Sett att framstella nya 5-metyl-7-hydroxi-isoflavonderivat
SE400295B (sv) Sett att framstella nya 2,6-diaminonebularinderivat
SE410600B (sv) Sett att framstella nya arylaminopyrimidinderivat
SE401176B (sv) Sett att framstella nya hypokalcemiskt verksamma dotriakontapeptidamider
SE386164B (sv) Sett att framstella nya 2-alkylamino-dihydropyridiner
SE399255B (sv) Sett att framstella kinazolinonderivat
SE417211B (sv) Sett att framstella indenyl-3-acetoglucuronider
SE405966B (sv) Sett att framstella peptider
SE400078B (sv) Sett att framstella kinazolinonderivat
BE802531A (fr) D-6-methyl-ergolines 2,8-disubstitutuees
SE384208B (sv) Sett att framstella nya 2,6-diamino-dihydropyridiner
SE385882B (sv) Sett att framstella nya 3,4-dihydropyridoner
SE7411948L (sv) Nya d-homosteroider.
SE413022B (sv) Sett att framstella nya propylendiaminderivat
SE400281B (sv) Sett att framstella kinazolinonderivat
SE7610170L (sv) Sett att framstella nya aminoimidazol-isokinolinderivat
SE396608B (sv) Sett att framstella nya penicilliner
SE403285B (sv) Sett att framstella nya 1,4-dihydrokinoliner
SE395007B (sv) Sett att framstella 9,10-seko-ostranderivat
SE7507619L (sv) Sett att framstella nya prostaglandiner.
SE7702331L (sv) Sett att framstella vinkamon